Sandbox brain abscess: Difference between revisions

Jump to navigation Jump to search
m (Replaced content with "__NOTOC__ {{CMG}} {{Brain abscess}} ==Overview== Treatment of brain abscess requires a multidisciplinary approach to delineate extent of infection, plan stereotactic traj...")
m (Changes made per Mahshid's request)
 
(15 intermediate revisions by one other user not shown)
Line 6: Line 6:
Treatment of brain abscess requires a multidisciplinary approach to delineate extent of infection, plan stereotactic trajectory, aspirate [[purulent]] materials, lower [[intracranial pressure]], identify causative pathogen, and administer appropriate [[antibiotics]].
Treatment of brain abscess requires a multidisciplinary approach to delineate extent of infection, plan stereotactic trajectory, aspirate [[purulent]] materials, lower [[intracranial pressure]], identify causative pathogen, and administer appropriate [[antibiotics]].


==Antimicrobial Therapy – Empiric Therapy==
{{rx|Preferred regimen}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}} 
* [[Metronidazole]] 30 mg/kg/day q6h
</li>
{{rx|Alternative regimen}}
* [[Meropenem]] 6 g/day q8h
</li>
{{rx|Transplant recipients}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}} 
* [[Metronidazole]] 30 mg/kg/day q6h {{and}} 
* [[Voriconazole]] 8 mg/kg/day q12h {{and}} 
* [[TMP-SMZ]] 10–20 mg/kg/day q6–12h {{or}} [[Sulfadiazine]] 4–6 g/day q6h
</li>
{{rx|Patients with HIV/AIDS}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}} 
* [[Sulfadiazine]] 4–6 g/day q6h {{and}} 
* [[Pyrimethamine]] 25–100 mg/day qd
</li>
{{rx|Staphylococcus aureus coverage}}
* [[Vancomycin]] 30–45 mg/kg/day q8–12h
</li>
{{rx|Mycobacterium tuberculosis coverage}}
* [[Isoniazid]] 300 mg qd {{and}} 
* [[Rifampin]] 600 mg qd {{and}} 
* [[Pyrazinamide]] 15–30 mg qd {{and}} 
* [[Ethambutol]] 15 mg/kg/day qd
</li>


 
==Antimicrobial Therapy – Pathogen-Based Therapy==
{{rx|Actinomyces}}
* [[Penicillin G]] 24 MU q4h
</li>
{{rx|Bacteroides fragilis}}
* [[Metronidazole]] 30 mg/kg/day q6h
</li>
{{rx|Enterobacteriaceae}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h
</li>
{{rx|Fusobacterium}}
* [[Metronidazole]] 30 mg/kg/day q6h
</li>
{{rx|Haemophilus}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h
</li>
{{rx|Listeria monocytogenes}}
* [[Ampicillin]] 12 g/day q4h {{or}} [[Penicillin G]] 24 MU q4h
</li>
{{rx|Nocardia}}
* [[TMP-SMZ]] 10–20 mg/kg/day q6–12h {{or}} [[Sulfadiazine]] 4–6 g/day q6h
</li>
{{rx|Prevotella melaninogenica}}
* [[Metronidazole]] 30 mg/kg/day q6h
</li>
{{rx|Pseudomonas aeruginosa}}
* [[Ceftazidime]] 6 g/day q8h {{or}} [[Cefepime]] 6 g/day q8h
</li>
{{rx|Methicillin-sensitive Staphylococcus aureus}}
* [[Nafcillin]] 12 g/day q4h {{or}} [[Oxacillin]] 12 g/day q4h
</li>
{{rx|Methicillin-resistant Staphylococcus aureus}}
* [[Vancomycin]] 30–45 mg/kg/day q8–12h
</li>
{{rx|Streptococcus anginosus and other streptococci}}
* [[Penicillin G]] 24 MU q4h
</li>
{{rx|Aspergillus}}
* [[Voriconazole]] 8 mg/kg/day q12h
</li>
{{rx|Candida}}
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
</li>
{{rx|Cryptococcus neoformans}}
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
</li>
{{rx|Mucorales}}
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
</li>
{{rx|Pseudallescheria boydii (Scedosporium apiospermum)}}
* [[Voriconazole]] 8 mg/kg/day q12h
</li>
{{rx|Toxoplasma gondii}}
* [[Sulfadiazine]] 4–6 g/day q6h {{and}} 
* [[Pyrimethamine]] 25–100 mg/day qd
</li>


==References==
==References==
Line 14: Line 97:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Infectious disease]]
 
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]

Latest revision as of 18:41, 18 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Abscess Main Page

Brain abscess Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brain abscess from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox brain abscess On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox brain abscess

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox brain abscess

CDC on Sandbox brain abscess

Sandbox brain abscess in the news

Blogs on Sandbox brain abscess

Directions to Hospitals Treating Brain abscess

Risk calculators and risk factors for Sandbox brain abscess

Overview

Treatment of brain abscess requires a multidisciplinary approach to delineate extent of infection, plan stereotactic trajectory, aspirate purulent materials, lower intracranial pressure, identify causative pathogen, and administer appropriate antibiotics.

Antimicrobial Therapy – Empiric Therapy

  • Antimicrobial Therapy – Pathogen-Based Therapy

  • References